{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:13:18Z","timestamp":1791238398224,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental and Toxicologic Pathology"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.etp.2008.03.005","type":"journal-article","created":{"date-parts":[[2008,6,4]],"date-time":"2008-06-04T08:49:51Z","timestamp":1212569391000},"page":"253-262","source":"Crossref","is-referenced-by-count":98,"title":["5-Hydroxytryptamine (5HT)-induced valvulopathy: Compositional valvular alterations are associated with 5HT2B receptor and 5HT transporter transcript changes in Sprague-Dawley rats"],"prefix":"10.1016","volume":"60","author":[{"given":"Chandikumar S.","family":"Elangbam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"Job","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah M.","family":"Zadrozny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna C.","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence W.","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa D.","family":"Gates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Slocum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.etp.2008.03.005_bib1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJM199707033370107","article-title":"Valvular heart disease","volume":"337","author":"Carabello","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.etp.2008.03.005_bib2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199708283370901","article-title":"Valvular heart disease associated with fenfluramine \u2013 phentermine","volume":"337","author":"Connolly","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.etp.2008.03.005_bib3","first-page":"451","article-title":"Systematic sampling in stereology","volume":"55","author":"Cruz-Orive","year":"1993","journal-title":"Bull Intern Statist Inst"},{"key":"10.1016\/j.etp.2008.03.005_bib4","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1093\/eurheartj\/ehm263","article-title":"In vivo model of drug-induced valvular heart disease in rats: pergolide-induced valvular heart disease demonstrated with echocardiography and correlation with pathology","volume":"28","author":"Droogmans","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.etp.2008.03.005_bib5","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1172\/JCI200112805","article-title":"Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension","volume":"108","author":"Eddahibi","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.etp.2008.03.005_bib6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/01926230290105703","article-title":"Endocardial myxomatous change in Harlan Sprague-Dawley rats (Hsd:S-D) and CD-1 mice: Its microscopic resemblance to drug-induced valvulopathy in humans","volume":"30","author":"Elangbam","year":"2002","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.etp.2008.03.005_bib7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1369\/jhc.4A6500.2005","article-title":"5-Hydroxytryptamine (5HT) receptors in the heart valves of cynomolgus monkeys and Sprague-Dawley rats","volume":"53","author":"Elangbam","year":"2005","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.etp.2008.03.005_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.etp.2006.08.001","article-title":"Evaluation of glycosaminoglycans content and 5-hydroxytryptamine 2B receptor in rat heart valves with spontaneous mitral valvulopathy \u2013 a possible exacerbation by dl-amphetamine sulfate in Fischer 344 rats?","volume":"58","author":"Elangbam","year":"2006","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.etp.2008.03.005_bib9","first-page":"L795","article-title":"A new role for an old molecule: serotonin as a mitogen","volume":"272","author":"Fanburg","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.etp.2008.03.005_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0026-895X(24)26444-0","article-title":"Possible role of valvular serotonin 5-HT2B receptors in the cardiopathy associated with fenfluramine","volume":"57","author":"Fitzgerald","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.etp.2008.03.005_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2818.1981.tb01199.x","article-title":"The efficiency of systematic sampling in stereology and its prediction","volume":"121","author":"Gundersen","year":"1987","journal-title":"J Microsc"},{"key":"10.1016\/j.etp.2008.03.005_bib12","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1161\/01.CIR.0000159356.42064.48","article-title":"Long-term serotonin administration induces heart valve disease in rats","volume":"111","author":"Gustafsson","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.etp.2008.03.005_bib13","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/mds.20201","article-title":"Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists","volume":"19","author":"Horvath","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.etp.2008.03.005_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejphar.2005.03.010","article-title":"Agonism at 5HT2B receptors is not a class effect of the ergolines","volume":"513","author":"Jahnichen","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.etp.2008.03.005_bib15","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM199809103391102","article-title":"A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation","volume":"339","author":"Jick","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.etp.2008.03.005_bib16","first-page":"16","article-title":"Second natural history study of congenital heart defects. Results of treatment of patients with aortic valvar stenosis","volume":"87","author":"Keane","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.etp.2008.03.005_bib17","doi-asserted-by":"crossref","first-page":"C766","DOI":"10.1152\/ajpcell.1986.250.5.C766","article-title":"Serotonin uptake by bovine pulmonary endothelial cells in culture, II: stimulation by hypoxia","volume":"250","author":"Lee","year":"1986","journal-title":"Am J Physiol"},{"key":"10.1016\/j.etp.2008.03.005_bib18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1054-8807(02)00110-2","article-title":"Quantitative analysis of human heart valves \u2013 does anorexigen exposure produce a distinctive morphological lesion?","author":"McDonald","year":"2002","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.etp.2008.03.005_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/CIRCULATIONAHA.105.554667","article-title":"Deficiency in the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice","volume":"113","author":"Mekontso-Dessap","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.etp.2008.03.005_bib20","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1124\/jpet.102.039867","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes","volume":"303","author":"Millan","year":"2002","journal-title":"J Pharmcol Exp Ther"},{"key":"10.1016\/j.etp.2008.03.005_bib21","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1161\/01.CIR.0000081520.25714.D9","article-title":"Functional consequence of serotonin\/5-HT2B receptor signaling in heart: role of mitochondria in transition between hypertrophy and heart failure?","volume":"108","author":"Nebigil","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.etp.2008.03.005_bib22","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1124\/jpet.102.039883","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT1 and 5-HT2 receptor subtypes","volume":"303","author":"Newman-Tancredi","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.etp.2008.03.005_bib23","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.4065\/77.12.1280","article-title":"Valvular heart disease in patients taking pergolide","volume":"77","author":"Pritchett","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.etp.2008.03.005_bib24","first-page":"827","article-title":"Cell proliferation in carcinoid valve disease: a mechanism for serotonin effects","volume":"10","author":"Rajamannan","year":"2001","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.etp.2008.03.005_bib25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1056\/NEJMp068265","article-title":"Drugs and valvular heart disease","volume":"356","author":"Roth","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.etp.2008.03.005_bib26","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1161\/01.CIR.102.23.2836","article-title":"Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications","volume":"102","author":"Rothman","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.etp.2008.03.005_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0163-7258(02)00234-6","article-title":"Therapeutic and adverse actions of serotonin transporter substrates","volume":"95","author":"Rothman","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.etp.2008.03.005_bib28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ijdevneu.2003.10.002","article-title":"Serotonin and its transporter on proliferation of fetal heart cells","volume":"21","author":"Sari","year":"2003","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.etp.2008.03.005_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa062222","article-title":"Dopamine agonists and the risk of cardiac-valve regurgitation","volume":"356","author":"Schade","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.etp.2008.03.005_bib30","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1124\/mol.63.6.1223","article-title":"3,4-Methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d) induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro","volume":"63","author":"Setola","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.etp.2008.03.005_bib31","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1517\/17425255.1.3.377","article-title":"Screening the receptorme reveals molecular targets responsible for drug-induced side effects: focus on \u2018fen-phen\u2019","volume":"1","author":"Setola","year":"2005","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.etp.2008.03.005_bib32","series-title":"Theory and practice of histotechnology","author":"Sheehan","year":"1980"},{"key":"10.1016\/j.etp.2008.03.005_bib33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0025-6196(11)62328-8","article-title":"Surgical pathology of carcinoid heart disease: a study of 139 valves from 75 patients spanning 20 years","volume":"77","author":"Simula","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.etp.2008.03.005_bib34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1054-8807(99)00019-8","article-title":"Histologic changes in three explanted native cardiac valves following use of fenfluramines","volume":"8","author":"Steffee","year":"1999","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.etp.2008.03.005_bib35","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1161\/CIRCULATIONAHA.105.171600","article-title":"American heart association statistics committee and stroke statistics subcommittee. Heart disease and stroke statistics \u2013 2006 update: a report from the American heart association statistics committee and stroke statistics subcommittee","volume":"113","author":"Thom","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.etp.2008.03.005_bib36","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(04)15945-X","article-title":"Treatment of parkinson's disease with pergolide and relation to restrictive valvular heart disease","volume":"363","author":"Van Camp","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.etp.2008.03.005_bib37","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.5858\/2001-125-1555-AAMFPV","article-title":"Aortic and mitral fenfluramine \u2013 phentermine valvulopathy in 64 patients treated with anorectic agents","volume":"125","author":"Volmar","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.etp.2008.03.005_bib38","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00000441-200104000-00008","article-title":"Appetite suppressants and valvular heart disease","volume":"321","author":"Weissman","year":"2001","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.etp.2008.03.005_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1056\/NEJMoa054830","article-title":"Valvular heart disease and the use of dopamine agonists for parkinson's disease","volume":"356","author":"Zanettini","year":"2007","journal-title":"N Engl J Med"}],"container-title":["Experimental and Toxicologic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0940299308000523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0940299308000523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T15:19:19Z","timestamp":1738250359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0940299308000523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":39,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0940299308000523"],"URL":"https:\/\/doi.org\/10.1016\/j.etp.2008.03.005","relation":{},"ISSN":["0940-2993"],"issn-type":[{"value":"0940-2993","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}